NanoKnife
Manufacturing · United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
United StatesWebsite
www.nanoknife.comRevenue
<$5 MillionIndustry
About NanoKnife
Is NanoKnife your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Product Launch: Get notified when NanoKnife launches new products
NanoKnife, which may be a good buyer, showed buying intent in Masked Content Topic
Check if NanoKnife has recently received funding, and reach out quickly before it becomes old news!
Earning: See what the market has to say on NanoKnife recently announced quarterly report
Funding: Get notified immidiatlly once NanoKnife has new funding data
Click to see if NanoKnife had a recent Job posting/layoffs
Website visits: Recent activity has been detected on your website
Congratulate Masked Content for being promoted to Masked Content at NanoKnife
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check out if NanoKnife is spiking on competitors!
Recommended Actions
Find VP level buyers at NanoKnife
Find more new buyers
Compare Similar Companies to NanoKnife
Compare insights from companies similar to NanoKnife, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
NanoKnife
Company Profile Activity
Activity Insights
NanoKnife is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
NanoKnife is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about NanoKnife.
NanoKnife Tech Stack
A closer look at the technologies used by NanoKnife
NanoKnife News & Media
AngioDynamics and University College London Hospital Launch International Multi-Center Study to Assess Long Term Effects of Treatment with The NanoKnife® System
LATHAM, N.Y.--(BUSINESS WIRE)--AngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative medical technology company focused on restoring healthy blood flow in the body’s vascular system, expanding cancer treatment options and improving patient quality of life, today announced the launch of an international multi-center prospective registry study to assess the long term effects of treating men with unifocal intermediate-risk prostate cancer with the NanoKnife® System in partnership with tAngioDynamics Completes Enrollment for PRESERVE Clinical Study
LATHAM, N.Y.--(BUSINESS WIRE)--AngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative medical technology company focused on restoring healthy blood flow in the body’s vascular system, expanding cancer treatment options and improving quality of life for patients, today announced the completion of enrollment and final treatment in its Pivotal Study of the NanoKnife System for Ablation of Prostate Tissue in an Intermediate-Risk Patient Population (PRESERVE). The PRESERVE study was initia
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding NanoKnife
The NanoKnife System reimagines localized ablation therapy through its unique mechanism of action and has treated more than 6000 patients worldwide. The system offers precise and customizable ablation zones, induces apoptotic-like cell death, and provides immediate real-time visualization. It is designed to effectively destroy cells without thermal... Read More